Drug Development and Industrial Pharmacy 2013-09-01

Coated hydralazine hydrochloride beads for sustained release after oral administration.

M Akhlaq Mughal, Kalyan K Saripella, Chahinaz Kouba, Zafar Iqbal, Steven H Neau

Index: Drug Dev. Ind. Pharm. 39(9) , 1439-46, (2013)

Full Text: HTML

Abstract

Hydralazine hydrochloride is an antihypertensive used alone or in combination with isosorbide nitrate for the treatment of congestive heart failure. Since control of blood pressure should be continuous, sustained release delivery of this drug is considered therapeutically beneficial. Core beads for oral administration of this drug were prepared by extrusion-spheronization. Using experimental design to define the coat that was applied, the core beads were coated using a fluid bed coater to different coat thickness with combinations of two commercially available products dissolved in a hydroalcoholic solvent. The coat is a film with a combination of ethylcellulose and hydroxypropylcellulose that can provide desirable release profiles. Visually spherical and rugged bead products were obtained. Two products were identified that exhibited essentially a zero order release profile following a 2-h lag time with release of greater than 70% of the drug over the next 10 h in simulated intestinal fluid.